Commonwealth Equity Services LLC raised its holdings in Waters Co. (NYSE:WAT) by 26.6% during the third quarter, Holdings Channel reports. The institutional investor owned 5,695 shares of the medical instruments supplier’s stock after buying an additional 1,195 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Waters were worth $1,271,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the business. First Trust Advisors LP acquired a new stake in Waters during the 1st quarter valued at $1,744,000. WINTON GROUP Ltd increased its stake in shares of Waters by 3.0% in the second quarter. WINTON GROUP Ltd now owns 121,999 shares of the medical instruments supplier’s stock worth $26,259,000 after acquiring an additional 3,586 shares during the last quarter. Crossmark Global Holdings Inc. increased its stake in shares of Waters by 7.8% in the second quarter. Crossmark Global Holdings Inc. now owns 7,397 shares of the medical instruments supplier’s stock worth $1,592,000 after acquiring an additional 536 shares during the last quarter. Zions Bancorporation N.A. increased its stake in shares of Waters by 5.0% in the second quarter. Zions Bancorporation N.A. now owns 1,611 shares of the medical instruments supplier’s stock worth $347,000 after acquiring an additional 76 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC increased its stake in shares of Waters by 194.5% in the second quarter. Douglass Winthrop Advisors LLC now owns 3,614 shares of the medical instruments supplier’s stock worth $778,000 after acquiring an additional 2,387 shares during the last quarter. 99.56% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have recently weighed in on the stock. Robert W. Baird upped their price target on shares of Waters from $208.00 to $217.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Needham & Company LLC reaffirmed a “hold” rating on shares of Waters in a research note on Tuesday, October 29th. Barclays downgraded shares of Waters from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $210.00 to $195.00 in a research note on Wednesday, October 9th. TheStreet downgraded shares of Waters from a “b” rating to a “c+” rating in a research note on Tuesday, October 29th. Finally, ValuEngine downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Six analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. Waters currently has a consensus rating of “Hold” and an average price target of $209.60.
Shares of NYSE:WAT opened at $213.39 on Thursday. The stock has a market capitalization of $13.54 billion, a PE ratio of 25.74, a P/E/G ratio of 2.50 and a beta of 1.04. Waters Co. has a 1 year low of $173.41 and a 1 year high of $255.21. The firm has a fifty day moving average price of $216.69 and a 200 day moving average price of $213.79. The company has a current ratio of 2.25, a quick ratio of 1.63 and a debt-to-equity ratio of 11.40.
Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, October 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $2.13. The firm had revenue of $577.28 million during the quarter, compared to analysts’ expectations of $588.35 million. Waters had a net margin of 23.98% and a return on equity of 77.73%. Waters’s revenue for the quarter was down .1% on a year-over-year basis. During the same period in the prior year, the company posted $1.92 earnings per share. On average, sell-side analysts forecast that Waters Co. will post 8.84 earnings per share for the current fiscal year.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More: Do You Need a Fiduciary?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.